Dr. Chhanda Charan Danta| Medicinal Chemistry | Best Researcher Award |

Florida International University,United States

Professional Profiles:

👨‍🎓 Bio Summary:

Dr. Chhanda Charan Danta is a self-driven scientist dedicated to advancing cancer, Alzheimer’s, and chronic disease research through cutting-edge medicinal chemistry and pharmacological screening. With a robust academic background, prestigious awards, and impactful research contributions, he is a leader in therapeutic innovation and translational science.

🎓 Educational Background:

Dr. Chhanda Charan Danta earned his Ph.D. in Pharmaceutical Chemistry from Panjab University, India, where his research focused on synthesizing and studying piperazine derivatives as potential cognition enhancers. He completed his Master’s in Pharmaceutical Chemistry at IIT-Banaras Hindu University, with work on designing and synthesizing quinazoline derivatives for anticancer and anticonvulsant activity. His academic journey began with a Bachelor’s degree in Pharmaceutical Sciences from Biju Patnaik University of Technology, where he explored antidepressant-like activity in benzilic acid derivatives.

🔍 Research Focus:

Dr. Danta’s research centers on anticancer and anti-Alzheimer’s drug discovery, diabetic kidney disease (DKD), and the tumor microenvironment. He specializes in synthesizing bioactive small molecules, bifunctional compounds for extracellular protein degradation, and molecular fluorescent probes. His multidisciplinary expertise spans medicinal chemistry, enzymology, and biological screening.

🏆 Honors & Awards:

Dr. Danta has received accolades such as the prestigious ACS Publications Award and recognition in retrosynthesis competitions, reaching the final round of the ISC-RSC Retrosynthesis Challenge 2022. He has been offered significant research positions, including Postdoctoral Associate at Florida International University and Associate Research Scientist at Yale University. Additionally, he was selected for a European Commission Horizon 2020 research project funded by the Innovative Medicines Initiative.

💼 Professional Experience:

Dr. Danta has held esteemed research roles at institutions like Yale University, where he contributed to molecular pharmacology and chemistry projects, including enzyme activation and extracellular protein degradation. Currently a Postdoctoral Associate at Florida International University, he focuses on synthesizing and screening bioactive small molecules. His career reflects advanced skills in molecular modeling, cellular assays, and drug discovery technologies

📚 Top Noted Publications :

The Discovery and Development of New Potential Antioxidant Agents for the Treatment of Neurodegenerative Diseases

Authors: CC Danta, P Piplani

Journal: Expert Opinion on Drug Discovery

Citations: 57

Index: 9(10), 1205-1222

Year: 2014

Antimicrobial Evaluation of Mangiferin and Its Synthesized Analogues

Authors: SK Singh, RM Tiwari, SK Sinha, CC Danta, SK Prasad

Journal: Asian Pacific Journal of Tropical Biomedicine

Citations: 48

Index: 2(2), S884-S887

Year: 2012

Calcium Channel Blockers: A Possible Potential Therapeutic Strategy for the Treatment of Alzheimer’s Dementia Patients with SARS-CoV-2 Infection

Author: CC Danta

Journal: ACS Chemical Neuroscience

Citations: 32

Index: –

Year: 2020

SARS-CoV-2, Hypoxia, and Calcium Signaling: The Consequences and Therapeutic Options

Author: CC Danta

Journal: ACS Pharmacol. Transl. Sci.

Citations: 28

Index: –

Year: 2021

Design and Synthesis of Newer Potential 4-(N-Acetylamino) Phenol Derived Piperazine Derivatives as Potential Cognition Enhancers

Authors: P Piplani, CC Danta

Journal: Bioorganic Chemistry

Citations: 27

Index: 60, 64-73

Year: 2015

Conclusion:

Dr. Chhanda Charan Danta’s profile highlights his innovative contributions to pharmaceutical chemistry, particularly in anticancer drug discovery and synthetic medicinal chemistry. His experience at prestigious institutions and his array of technical skills make him a compelling candidate for the “Best Researcher Award.”

👨‍🎓 Bio Summary:

Prof. Dr. Ameen Abu-Hashem is a distinguished figure in the field of organic chemistry, renowned for his contributions to the development of synthetic methodologies for biologically interesting heterocyclic compounds. He is currently affiliated with the Department of Photochemistry at the Chemical Industrial Institute, National Research Centre (NRC), Egypt, and the Faculty of Science, Chemistry Department, Jazan University, Saudi Arabia.

🎓 Education:

Prof. Abu-Hashem obtained his Bachelor of Science in Chemistry from Zagazig University, followed by a Master of Science in Organic Chemistry from El-Mansora University. He completed his Ph.D. in Organic Chemistry at Cairo University, where he conducted research under the supervision of Prof. Abdel-Samei Mahmoud Abdel-Fattah and Prof. Mohamed M. Youssef.

🔍 Research Focus:

Prof. Abu-Hashem’s research focuses on the development of novel synthetic methodologies, particularly in the synthesis of pyrimidine derivatives and nucleosides analogues with potential biological activities such as anti-inflammatory, analgesic, antiviral, and antioxidant properties. His work also includes the synthesis of antifouling polymers and the study of their biological and ecological activities.

🏆 Honors & Awards:

Prof. Abu-Hashem has received several prestigious honors and awards for his outstanding contributions to the field of organic chemistry. Notably, he has been listed among the best-distinguished scientists globally by Stanford University and has been selected as the Best Researcher in organic chemistry and medicinal chemistry by the global Science Father Foundation.

Professional Experience: 💼

With a rich professional history, Prof. Abu-Hashem has held various roles, including positions at Sekam Company, the Environment System of Egypt, and the National Research Centre (NRC), Egypt. He has served as an Assistant Professor and later as a Professor of Organic Chemistry, demonstrating a strong commitment to academia and research.

📚 Top Noted Publications :

Title: Synthesis, anticancer activity and molecular docking of new quinolines, quinazolines and 1, 2, 4-triazoles with pyrido [2, 3-d] pyrimidines

Authors: AA Abu-Hashem, O Hakami, N Amri

Journal: Heliyon, 2024, 10, e26735

Title: Synthesis of 1,3,5-Triazepines and Benzo[f ][1,3,5]triazepines and Their Biological Activity: Recent Advances and New Approaches

Authors: AA Abu-Hashem, O Hakami, N Amri, YE Mukhrish, AAM Abdelgawad

Journal: Molecules, 2024, 29 (3), 632

Title: Pyrimido[5,4-c]quinolines: Synthesis from 3,4-Di-functionallized Quinoline, Reactivity and Biological Activities

Authors: MA Gouda, AA Abu-Hashem, TA Ahmed, SH Althagafi, Waffa Hamama

Journal: Chemistry and Biodiversity, 2024/01/09, Accepted; DOI:10.1002/cbdv.202301968

Title: Synthesis, Reactions and Biological Activity of Pyrimido [5, 4-c] quinolines based on (thio)barbituric acid and their analogous (Part IV)

Authors: AA Abu-Hashem, TA Ameen, EM El-Telbani, HAR Hussein, MA Gouda

Journal: Mini-Reviews in Organic Chemistry, 2024; DOI: 10.2174 …

Title: Chemistry and Biological Activity of Thieno[3,4-b] quinoline, Thieno[3,4-c] quinolone, Thieno[3,2-g] quinoline and Thieno[2,3-g] quinoline Derivatives: A Review (Part IX)

Authors: AA Abu-Hashem, AAM Abdelgawad, MA Gouda

Journal: Mini-Reviews in Organic Chemistry, 2024, 21 (7), 764 – 778

Title: Chemistry of Thieno [2,3-h]-/[3,2-h] quinoline and Thieno [2,3-f]-/[3,2-f] quinoline derivatives part (x), Reactivities, and Biological Activities

Authors: MA Gouda, NA Al-Hadhrami, AA Abu-Hashem, AAM Abdelgawad

Journal: Mini-Reviews in Organic Chemistry, 2024, 21 (6), 671-683.

Author Metrics 📊 :

Prof. Abu-Hashem’s research has garnered significant attention, as evidenced by his author metrics. His publications have been cited extensively, highlighting the impact of his work within the scientific community.

📅 Research Timeline:

Prof. Abu-Hashem’s research journey spans several decades, with significant milestones and contributions to the field of organic chemistry. His dedication to advancing scientific knowledge and exploring new frontiers in synthetic chemistry has made him a respected figure in the academic community.